Obesity

Cost-Effectiveness of Pharmacotherapy for the Treatment of Obesity in Adolescents

JAMA Netw OpenPublished Economic evaluation

Authors' conclusion

In this economic evaluation of pharmacotherapy for adolescents with obesity, top-dose phentermine and topiramate as adjunct to lifestyle counseling was estimated to be cost-effective after 5 years. Long-term clinical trials in adolescents are needed to fully evaluate the outcomes of pharmacotherapy, especially into adulthood.

Study context

Population
Hypothetical cohort of adolescents with obesity, age 15, initial body mass index (BMI) 37; 58% female
Participants
100,000 simulated adolescents
Exposure
Lifestyle counseling alone vs adjunct liraglutide, mid-dose phentermine/topiramate, top-dose phentermine/topiramate or semaglutide
Outcome
QALYs, costs (2022 US dollars) and incremental cost-effectiveness ratios (ICERs); cost-effective if ICER <$100 000 per QALY gained
Follow-up
13 months, 2 years, and 5 years
Methodological detailscost-effectiveness microsimulation model, hypothetical cohort, costs and quality-adjusted life years (QALYs) discounted 3.0% annually, one-way and probabilistic sensitivity analyses, Model inputs from clinical trials, published literature and national sources; data analysed April 2022 to July 2023
  • Cost-effectiveness microsimulation model
  • Hypothetical cohort
  • Costs and QALYs discounted 3.0% annually
  • One-way and probabilistic sensitivity analyses
  • Model inputs from clinical trials, published literature and national sources; data analysed April 2022 to July 2023

Main finding

As reported in the abstract

Preferred strategy (cost-effectiveness) · 5 years

ICER

$56 876 per QALY gained

Top-dose phentermine and topiramate vs Lifestyle counseling · preferred strategy at 5 years

ICER

$1.1 million per QALY gained

Semaglutide vs Top-dose phentermine and topiramate · unfavorable; semaglutide yielded the most QALYs

Observational data: associations, not effects.

Further findings

Preferred strategy at 13 months and 2 years

Lifestyle counseling estimated to be the preferred strategy

Sensitivity analyses

Results most sensitive to utility of weight reduction and weight loss of lifestyle counseling and top-dose phentermine and topiramate

Original publication

Cost-Effectiveness of Pharmacotherapy for the Treatment of Obesity in Adolescents. JAMA Netw Open. Published 1 August 2023. doi:10.1001/jamanetworkopen.2023.29178

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.